Alimta

... Bloomberg.com: U.S.

Updated: New York: Oct 20 09:00London: Oct 20 14:00Tokyo: Oct 20 22:00 US AUBZFPGRHKIMJPLNSMIND : Regions Top Worldwide Regions Asia Australia & New Zealand Canada Europe Germany Japan Latin America U.K.

U.S.

Markets Economy/Politics Commentary Sports Culture RESOURCES: Bloomberg TV Bloomberg Radio Markets U.S.

E-Mail This Story Printer-Friendly Format Pfizer's Earnings Plunge 52 Percent on Lower Sales of Celebrex Painkiller Ford Posts Loss of $284 Million on Lower SUV Sales, Its First Since 2003 Eli Lilly Net Income Rises on Sales of Antidepressants, Cancer Treatments Lilly's 3rd-Qtr Profit Rises 5.2% on New Drugs (Update2) Oct.

20 (Bloomberg) - Eli Lilly & Co.

said third-quarter profit rose 5.2 percent as it controlled costs and sold more of its newer medicines, such as the Cymbalta antidepressant and Net income for Lilly rose to $794.4 million, or 73 cents a share, from $755 million, or 69 cents, a year earlier, Indianapolis-based Lilly said in a statement.

Sales rose 10 percent to $3.6 billion, while Lilly's cost to produce these medicines rose 4 percent to $845.7 million.

Lilly is planning on saving $150 million this year through costs cuts, including job reductions announced in 2004, according to the company Web site.

U.S.

sales of its Strattera attention-deficit-disorder drug and the Zyprexa schizophrenia treatment, Lilly's biggest product, fell because of concerns about side aff...

... FDA Advisory Committee "The Pink Sheet" "The Tan Sheet" Health News Daily Other FDC Pubs.

Pharmaceutical Approvals NDA Pipeline "The Gold Sheet" "The Blue Sheet" "The Gray Sheet" "The Silver Sheet" "The Rose Sheet" MY PREFERENCES CONTACT US Allergenic Products Anesthetic and Life Support Drugs Anti-Infective Drugs Pediatric Subcommittee Antiviral Drugs Immunosuppressive Drugs Arthritis Drugs Blood Products Cardiovascular and Renal Drugs Cellular, Tissue and Gene Therapies Biological Response Modifiers Dermatologic and Ophthalmic Drugs Device Panels Drug Safety and Risk Mgmt Drug Abuse Endocrinologic and Metabolic Drugs Gastrointestinal Drugs Medical Imaging Drugs Nonprescription Drugs Oncologic Drugs Pediatric Pediatric Ethics Subcmte.

Peripheral and Central Nervous System Drugs Pharmaceutical Science Nonclinical Studies Manufacturing Pharmacology/Toxicology Clinical Pharmacology Orally Inhaled & Nasal Drug Products Pharmacy Compounding Psychopharmacologic Drugs Public Meetings Pulmonary-Allergy Drugs Reproductive Health Drugs Science Board Transmissible Spongiform Encephalopathies Vaccines and Related Biological Products A D V E R T I S E M E N T Oncologic Committee To Meet Nov.

8 On Accelerated Approval Commitments FDA will seek advice from its Oncologic Drugs Advisory Committee on how sponsors can better execute studies to complete postmarketing commitments for accelerated approval drugs.

The committee wil...

... Tomudex® Plus Platinol® Improves Survival of Patients with Malignant Pleural Mesothelioma Oncology Information Home page About Us Search CancerConsultants.com • CME • Conference Coverage • Current Topics • Professional News • Drug Pipeline Main Menu Quick Links Information by Disease All Acute Leukemia Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Cervical Cancer Chronic Leukemia Colon Cancer Gastric Cancer Head and Neck Cancers Liver Lung Cancer Lymphoma Myelodysplastic Syndrome Melanoma Mesothelioma Multiple Myeloma NSCLC Ovarian Cancer Pancreatic Cancer Prostate Cancer Rectal Cancer Renal Cancer SCLC Cancer News Select Cancer Type Anal Cancer Anemia Bladder Cancer Brain and CNS Cancers Breast Cancer CAM Carcinoid Tumors Cervical Cancer CINV Colon Cancer Esophageal Cancer Gastric Cancer General Head and Neck Cancers HIV Cancers Hodgkin's Lymphoma Leukemia Liver Lung Cancer Melanoma Mesothelioma Mucositis Multiple Myeloma Myelodysplastic Syndrome Neuroblastoma Neutropenia Non-Hodgkin's Lymphoma NSCLC Ovarian Cancer Pancreatic Cancer Prostate Cancer Rectal Cancer Renal Cancer SCLC News Skin Cancer Stem Cell Transplant Supportive Care Testicular Cancer Thyroid Cancer Uterine Cancer Conference Coverage Select Conference 2005 Conference Coverage 2004 Conference Coverage 2003 Conference Coverage 2002 Conference Coverage 2001 Conference Coverage Make Home Page Add to Favorites Cancer News Articles Ca...